FDA Gives Green Light to Oral Version of Novo Nordisk’s Wegovy, Expanding Weight Loss Options

The FDA has granted approval for the oral formulation of Novo Nordisk’s Wegovy, originally an injectable treatment for weight management. This marks the first approval of a GLP-1 receptor agonist in pill form for obesity treatment, potentially broadening patient access to this therapy.